Mariner
PCVX icon

Mariner’s Vaxcyte PCVX Stock Holding History

Mariner’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$754K Buy
12,980
+4,441
+52% +$241K ﹤0.01% 2171
2025
Q4 		$394K Buy
8,539
+784
+10% +$35.1K ﹤0.01% 2628
2025
Q3 		$279K Buy
+7,755
New +$257K ﹤0.01% 2873
2025
Q2 		– Sell
-7,945
Closed -$300K – 3632
2025
Q1 		$300K Buy
7,945
+1,998
+34% +$160K ﹤0.01% 2623
2024
Q4 		$487K Buy
5,947
+1,290
+28% +$128K ﹤0.01% 2216
2024
Q3 		$531K Buy
4,657
+465
+11% +$41.9K ﹤0.01% 2082
2024
Q2 		$317K Buy
4,192
+502
+14% +$34.2K ﹤0.01% 2409
2024
Q1 		$252K Buy
+3,690
New +$256K ﹤0.01% 2589

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mariner's PCVX Position: Q1 2026 in Review

Mariner increased its Vaxcyte (PCVX) stake by 52% in Q1 2026, buying an estimated $241K and bringing the position to 12,980 shares worth $754K. The position accounts for ﹤0.01% of the portfolio, ranked #2171.

Mariner first reported a position in PCVX in Q1 2024 and has held it in 8 quarters since. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • Mariner held 12,980 shares of Vaxcyte worth $754K as of Q1 2026.
  • Mariner bought 4,441 Vaxcyte shares in Q1 2026, an estimated $241K.
  • Vaxcyte made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2171 holding.
  • Mariner first reported a position in Vaxcyte in Q1 2024 and has held it in 8 quarters since.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.